The impact of acquisition time of planar cardiac 123I-MIBG imaging on the late heart to mediastinum ratio
Creators
- 1. Leiden University Medical Center, Department of Cardiology, Leiden (Netherlands)
- 2. Fondazione Toscana/CNR Gabriele Monasterio, Pisa (Italy)
- 3. VieCuri, Department of Nuclear Medicine, Venlo (Netherlands)
- 4. Academic Medical Center, Department of Nuclear Medicine, Amsterdam (Netherlands)
- 5. Leiden University Medical Center, Department of Medical Statistics and Bio-informatics, Leiden (Netherlands)
- 6. Leiden University Medical Center, Department of Nuclear Medicine, Leiden (Netherlands)
Description
The aim of this study was to investigate whether performing the late cardiac 123I-metaiodobenzylguanidine (MIBG) scan earlier than 4 h post-injection (p.i.) has relevant impact on the late heart to mediastinum ratio (H/M ratio) in patients with heart failure (HF). Forty-nine patients with HF (median left ventricular ejection fraction of 31 %, 51 % ischaemic HF) referred for cardiac 123I-MIBG scintigraphy were scanned at 15 min (early) p.i. and at 1, 2, 3 and 4 h (late) p.i. of 123I-MIBG. Late H/M ratios were calculated and evaluated using a linear mixed model with the mean late H/M ratio at 4 h p.i. as a reference. A difference in late H/M ratios of more than 0.10 between the different acquisition times in comparison with the late H/M ratio at 4 h p.i. was considered as clinically relevant. Statistically significant mean differences were observed between the late H/M ratios at 1, 2 and 3 h p.i. compared with the late H/M ratio at 4 h p.i. (0.09, 0.05 and 0.02, respectively). However, the mean differences did not exceed the cut-off value of 0.10. On an individual patient level, compared to the late H/M ratio at 4 h p.i., the late H/M ratios at 1, 2 and 3 h p.i. differed more than 0.10 in 24 (50 %), 9 (19 %) and 2 (4 %) patients, respectively. Variation in acquisition time of 123I-MIBG between 2 and 4 h p.i. does not lead to a clinically significant change in the late H/M ratio. An earlier acquisition time seems to be justified and may warrant a more time-efficient cardiac 123I-MIBG imaging protocol. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-015-3220-5Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 43
- Journal Issue
- 2
- Journal Page Range
- p. 326-332
- ISSN
- 1619-7070
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 47040417
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- GAMMA CAMERAS; HEART; INJECTION; IODINE 123; ISCHEMIA; MEDIASTINUM; MEGA BQ RANGE 100-1000; MIBG; RADIOISOTOPE SCANNERS; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS; SCINTISCANNING; THYROID
- Descriptors DEC
- ANEMIAS; AROMATICS; BETA DECAY RADIOISOTOPES; BODY; CAMERAS; CARBONIC ACID DERIVATIVES; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CHEST; COUNTING TECHNIQUES; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; ELECTRON CAPTURE RADIOISOTOPES; ENDOCRINE GLANDS; GLANDS; GUANIDINES; HEMIC DISEASES; HOURS LIVING RADIOISOTOPES; INTAKE; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MATHEMATICS; MEGA BQ RANGE; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANIC HALOGEN COMPOUNDS; ORGANIC IODINE COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; RADIOACTIVE MATERIALS; RADIOACTIVITY RANGE; RADIOISOTOPE SCANNING; RADIOISOTOPES; STATISTICS; SYMPTOMS; VASCULAR DISEASES